Metals versus microbes: The biocidal effect of metalloacid-coated surfaces

November 13, 2012

A new study published in BioMed Central's open access journal Antimicrobial Resistance and Infection Control reports of a phenomenon that could help control the spread of hospital-acquired infections: a surface-coating of metalloacids kills off microbial strains, even in multidrug-resistant microorganisms.

Hospital infections are a major public health concern, causing an estimated 99,000 deaths a year in the USA alone. Cleaning and disinfecting surfaces greatly helps reduce these infections. In addition, previous studies have indicated that metalloacids could limit the ability of microorganisms to survive by producing oxonium ions (H3O+), which creates an acidic pH.

In this novel study, the authors from the Centre Hospitalier Universitaire de Tours and the Centre Hospitalier Universitaire de Besançon, France, set out to test the biocidal ability of molybdenum trioxide metalloacid-coated surfaces. To do this, they contaminated metalloacid-coated and non-coated surfaces by exposing them to microbial suspensions of eleven different microorganisms responsible for .

The microorganisms tested were two strains, Clostridium difficile, three extended-spectrum beta-lactamase-producing Enterobacteriaceae strains, vancomycin-resistant vanA Enterococcus faecium, Psuedomonas aeruginosa, multidrug-resistant Acinetobacter baumanii, and two fungal strains of and Aspergillus fumigatus.

The authors found that the metalloacid-coated surfaces exhibited significant in all non-spore-forming organisms tested within 2-6 hours of initial contact. The coated surfaces greatly limited the survival of microorganisms, whereas microorganism numbers remained substantial on non-coated surfaces. Interestingly, spore-forming organisms were completely unaffected by the coated surfaces.

The biocidal reaction is thought to be caused by the diffusion H3O+ ions through membranes, resulting in altered enzyme transport systems and inhibited metabolic activity.

Lead author Nathalie van der Mee-Marquet thinks that the findings of this study could greatly aid hospitals in controlling infection. She said, "In contrast to disinfectants and antibiotics, microbial resistance to metalloacids may not emerge, and they should be safe for human use. A molybdenum trioxide coating may be an effective and permanent means of minimizing microbial contamination between hospital cleaning procedures, particularly against multidrug-resistant organisms."

van der Mee-Marquet suggests that further studies should evaluate the benefits of the coating on medical devices and gauge whether it can be used as a complementary measure in hospitals for preventing the spread of nosocomial infections.

Explore further: Penicillin-coated biomaterial created

More information: Biocidal activity of metalloacid-coated surfaces against multidrug-resistant microorganisms. Nathalie Tetault, Houssein Gbaguidi-Haore, Xavier Bertrand, Roland Quentin and Nathalie Van Der Mee-Marquet, Antimicrobial Resistance and Infection Control (in press)

Related Stories

Penicillin-coated biomaterial created

January 17, 2007

U.S. scientists have developed a penicillin-coated version of a polymer biomaterial to protect polymer-based surgical devices and medical implants.

Can we 'wipe out' MRSA?

June 3, 2008

Three basic principles is all it could take to reduce the incidence of MRSA in hospitals according to a new research by Cardiff University.

Copper reduces infection risk by more than 40 percent

July 1, 2011

Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, has presented research into the mechanism by which copper exerts its antimicrobial ...

New non-toxic disinfectant could tackle hospital infections

August 7, 2012

A new disinfectant, Akwaton, that works at extremely low concentrations could be used in healthcare settings to help control persistent hospital-acquired infections such as Clostridium difficile. The study is reported online ...

Recommended for you

New drug to fight fatal but neglected tropical disease

August 31, 2016

In a breakthrough for those infected by the parasites that cause sleeping sickness, a young Queensland researcher has identified a compound that kills the parasites in the lab without having any toxic effect on human cells.

Traces of Ebola virus linger longer than expected in semen

August 31, 2016

Initial data from a Liberian public health program show about 9 percent (38) of 429 male Ebola survivors had fragments of Ebola virus in their semen. Of those, 63 percent had semen samples that tested positive for Ebola fragments ...

Researchers discover a drug for a tropical disease

August 30, 2016

Researchers at the University of Georgia are working to find the fastest way possible to treat and cure human African trypanosomiasis, long referred to as sleeping sickness. By working to improve chemical entities already ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.